Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids

NCT01483833 is registered in ClinicalTrials.gov with Ventrus Biosciences, Inc as lead sponsor.

NCT NCT01483833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01483833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids
Lead sponsor
Ventrus Biosciences, Inc
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
August 31, 2002
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids